Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis.

van den Broek WW, Mulder PG, van Os E, Birkenhäger TK, Pluijms E, Bruijn JA.

J Psychopharmacol. 2009 Aug;23(6):708-13. doi: 10.1177/0269881108089821. Epub 2008 Jun 18. Review.

PMID:
18562424
[PubMed - indexed for MEDLINE]
2.

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis.

Smith D, Dempster C, Glanville J, Freemantle N, Anderson I.

Br J Psychiatry. 2002 May;180:396-404. Review.

PMID:
11983635
[PubMed - indexed for MEDLINE]
Free Article
3.

Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons.

Eckert L, Lançon C.

BMC Psychiatry. 2006 Jul 24;6:30. Review.

PMID:
16867188
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Pharmacologic profile and efficacy of venlafaxine.

Mendlewicz J.

Int Clin Psychopharmacol. 1995 Mar;10 Suppl 2:5-13. Review.

PMID:
7622816
[PubMed - indexed for MEDLINE]
5.

Clinical evaluation of venlafaxine.

Ballenger JC.

J Clin Psychopharmacol. 1996 Jun;16(3 Suppl 2):29S-35S; discussion 35S-36S. Review.

PMID:
8784646
[PubMed - indexed for MEDLINE]
6.

Clinical utility of venlafaxine in comparison with other antidepressants.

Lecrubier Y.

Int Clin Psychopharmacol. 1995 Mar;10 Suppl 2:29-35. Review.

PMID:
7622815
[PubMed - indexed for MEDLINE]
7.

Safety and tolerability of the new antidepressants.

Nelson JC.

J Clin Psychiatry. 1997;58 Suppl 6:26-31. Review.

PMID:
9227670
[PubMed - indexed for MEDLINE]
8.

Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion.

Horst WD, Preskorn SH.

J Affect Disord. 1998 Dec;51(3):237-54. Review.

PMID:
10333980
[PubMed - indexed for MEDLINE]
9.

Are all antidepressants really the same? The case of fluoxetine: a systematic review.

Cipriani A, Barbui C, Brambilla P, Furukawa TA, Hotopf M, Geddes JR.

J Clin Psychiatry. 2006 Jun;67(6):850-64. Review.

PMID:
16848644
[PubMed - indexed for MEDLINE]
10.

The pharmacoeconomics of venlafaxine in depression.

Morrow TJ.

Am J Manag Care. 2001 Sep;7(11 Suppl):S386-92. Review.

PMID:
11570029
[PubMed - indexed for MEDLINE]
Free Article
11.

[Pharmacological justification for the use of new antidepressant drugs].

Nowakowska E, Kus K, Bobkiewicz-Kozłowska T.

Pol Merkur Lekarski. 2002 Sep;13(75):250-2. Review. Polish.

PMID:
12474581
[PubMed - indexed for MEDLINE]
12.

Safety and tolerance profile of venlafaxine.

Danjou P, Hackett D.

Int Clin Psychopharmacol. 1995 Mar;10 Suppl 2:15-20. Review.

PMID:
7622813
[PubMed - indexed for MEDLINE]
13.

Which antidepressants have demonstrated superior efficacy? A review of the evidence.

Montgomery SA, Baldwin DS, Blier P, Fineberg NA, Kasper S, Lader M, Lam RW, Lépine JP, Möller HJ, Nutt DJ, Rouillon F, Schatzberg AF, Thase ME.

Int Clin Psychopharmacol. 2007 Nov;22(6):323-9. Review. Erratum in: Int Clin Psychopharmacol. 2008 Jan;23(1):61.

PMID:
17917550
[PubMed - indexed for MEDLINE]
14.

Rapid onset of action of venlafaxine.

Montgomery SA.

Int Clin Psychopharmacol. 1995 Mar;10 Suppl 2:21-7. Review.

PMID:
7622814
[PubMed - indexed for MEDLINE]
15.

Cardiovascular safety in depressed patients: focus on venlafaxine.

Feighner JP.

J Clin Psychiatry. 1995 Dec;56(12):574-9. Review.

PMID:
8530334
[PubMed - indexed for MEDLINE]
16.

Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.

Stabl M, Biziére K, Schmid-Burgk W, Amrein R.

J Neural Transm Suppl. 1989;28:77-89. Review.

PMID:
2677244
[PubMed - indexed for MEDLINE]
17.

New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.

Owen JR, Nemeroff CB.

Depress Anxiety. 1998;7 Suppl 1:24-32. Review.

PMID:
9597349
[PubMed - indexed for MEDLINE]
18.

Venlafaxine: a novel antidepressant that has a dual mechanism of action.

Andrews JM, Ninan PT, Nemeroff CB.

Depression. 1996;4(2):48-56. Review.

PMID:
9160640
[PubMed - indexed for MEDLINE]
19.

Efficacy of venlafaxine in the treatment of severe depression.

Kienke AS, Rosenbaum JF.

Depress Anxiety. 2000;12 Suppl 1:50-4. Review.

PMID:
11098414
[PubMed - indexed for MEDLINE]
20.

Venlafaxine: a 2003 update.

Gutierrez MA, Stimmel GL, Aiso JY.

Clin Ther. 2003 Aug;25(8):2138-54. Review.

PMID:
14512125
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk